Compare, Analyse ALEMBIC with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs MYLAN (US) - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC   MYLAN
EQUITY SHARE DATA
    ALEMBIC
Mar-18
MYLAN
Dec-18
ALEMBIC/
MYLAN
5-Yr Chart
Click to enlarge
High Rs723,498-   
Low Rs341,925-   
Sales per share (Unadj.) Rs4.71,609.6-  
Earnings per share (Unadj.) Rs6.143.7-  
Cash flow per share (Unadj.) Rs6.2345.1-  
Dividends per share (Unadj.) Rs0.200-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs40.71,741.3-  
Shares outstanding (eoy) m267.03514.50-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x11.31.7 668.6%   
Avg P/E ratio x8.762.0 14.0%  
P/CF ratio (eoy) x8.57.9 107.9%  
Price / Book Value ratio x1.31.6 83.6%  
Dividend payout %3.30-   
Avg Mkt Cap Rs m14,1391,395,211 1.0%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m2070-   
Avg. sales/employee Rs ThNM23,661.7-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM642.5-  
INCOME DATA
Net Sales Rs m1,255828,159 0.2%  
Other income Rs m3700-   
Total revenues Rs m1,625828,159 0.2%   
Gross profit Rs m111214,297 0.1%  
Depreciation Rs m38155,064 0.0%   
Interest Rs m239,832 0.0%   
Profit before tax Rs m44219,401 2.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24-3,087 -0.8%   
Profit after tax Rs m1,63022,488 7.2%  
Gross profit margin %8.925.9 34.2%  
Effective tax rate %5.4-15.9 -34.1%   
Net profit margin %129.82.7 4,781.9%  
BALANCE SHEET DATA
Current assets Rs m1,867462,443 0.4%   
Current liabilities Rs m591337,172 0.2%   
Net working cap to sales %101.615.1 672.0%  
Current ratio x3.21.4 230.3%  
Inventory Days Days9484 112.8%  
Debtors Days Days7493 78.8%  
Net fixed assets Rs m1,791160,649 1.1%   
Share capital Rs m534441 121.1%   
"Free" reserves Rs m10,3240-   
Net worth Rs m10,858895,917 1.2%   
Long term debt Rs m41966,981 0.0%   
Total assets Rs m11,5912,403,196 0.5%  
Interest coverage x260.91.5 17,543.2%   
Debt to equity ratio x01.1 0.4%  
Sales to assets ratio x0.10.3 31.4%   
Return on assets %14.12.6 542.8%  
Return on equity %15.02.5 598.0%  
Return on capital %15.23.2 477.7%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Net fx Rs m-2440-   
CASH FLOW
From Operations Rs m236172,092 0.1%  
From Investments Rs m-224-88,952 0.3%  
From Financial Activity Rs m-27-80,170 0.0%  
Net Cashflow Rs m-151,426 -1.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.49 Rs / USD

Compare ALEMBIC With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC With: GSK PHARMA  FRESENIUS KABI ONCO.  AJANTA PHARMA  FDC  LUPIN  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

New Research: Our #1 Stock Pick Right Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ALEMBIC SHARE PRICE


May 14, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC

ALEMBIC 5-YR ANALYSIS

COMPARE ALEMBIC WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS